Related Experiment Video
Updated: Aug 17, 2026

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
Regulation of apoptosis by alternative pre-mRNA splicing
Christian Schwerk1, Klaus Schulze-Osthoff
1Institute of Molecular Medicine, University of Düsseldorf, Building 23.12, Universitätsstrasse 1, 40225 Düsseldorf, Germany.
Abstract:
Apoptosis, a phenomenon that allows the regulated destruction and disposal of damaged or unwanted cells, is common to many cellular processes in multicellular organisms. In humans more than 200 proteins are involved in apoptosis, many of which are dysregulated or defective in human diseases including cancer. A large number of apoptotic factors are regulated via alternative splicing, a process that allows for the production of discrete protein isoforms with often distinct functions from a common mRNA precursor. The abundance of apoptosis genes that are alternatively spliced and the often antagonistic roles of the generated protein isoforms strongly imply that alternative splicing is a crucial mechanism for regulating life and death decisions. Importantly, modulation of isoform production of cell death proteins via pharmaceutical manipulation of alternative splicing may open up new therapeutic avenues for the treatment of disease.
Insights
Alternative splicing regulates apoptosis, the process of programmed cell death, by producing different protein versions. This mechanism is crucial for cell fate decisions and offers potential therapeutic targets for diseases like cancer.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- Apoptosis is essential for multicellular organisms, involving over 200 human proteins.
- Dysregulation of apoptotic proteins is linked to diseases, notably cancer.
- Alternative splicing generates diverse protein isoforms from a single mRNA.
Purpose of the Study:
- To highlight the critical role of alternative splicing in regulating apoptosis.
- To explore the implications of alternative splicing in disease pathogenesis.
- To investigate the therapeutic potential of modulating alternative splicing for cell death proteins.
Main Methods:
- Analysis of alternative splicing patterns in apoptosis-related genes.
- Functional characterization of alternatively spliced protein isoforms.
- Review of existing literature on splicing factors and apoptosis.
Main Results:
- A significant number of apoptosis-related genes are subject to alternative splicing.
- Generated protein isoforms often exhibit opposing functions, influencing cell survival or death.
- Alternative splicing is a key regulatory mechanism for life-and-death decisions in cells.
Conclusions:
- Alternative splicing is a fundamental process controlling apoptosis.
- Aberrant splicing of apoptotic factors contributes to disease development.
- Targeting alternative splicing presents a promising therapeutic strategy for cancer and other diseases.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing
RNA Splicing
Pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl guanosine). This 5’ cap helps the...
pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl guanosine). This 5’ cap helps the...

